The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.

about

The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.Change in novel filtration markers and risk of ESRD.Diabetic nephropathy: the proteinuria hypothesis.

P2860

Q33325660-F83B2FA2-C213-47D3-91A5-E84D8C42A7D3 Q35772896-561B5BC8-3664-447F-B131-D8219DA2E9DB Q36061335-DD94269C-C985-4444-9B9E-173CE2D5A630

P2860

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.

Item

http://www.wikidata.org/entity/Q40753379

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

The future of clinical trials ...... nic Renal Disease Study Group.

@en

type

Item

label

The future of clinical trials ...... nic Renal Disease Study Group.

@en

prefLabel

The future of clinical trials ...... nic Renal Disease Study Group.

@en

P1476

The future of clinical trials ...... nic Renal Disease Study Group.

@en

P2093

Bakris GL

http://www.w3.org/2001/XMLSchema#string

Keane W

http://www.w3.org/2001/XMLSchema#string

Mimran A

http://www.w3.org/2001/XMLSchema#string

Schiffrin E

http://www.w3.org/2001/XMLSchema#string

Weir M

http://www.w3.org/2001/XMLSchema#string

Whelton P

http://www.w3.org/2001/XMLSchema#string

P2860

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients.

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study.

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.

Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study.

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency.

Understanding the nature of renal disease progression.

Pathogenesis and course of renal disease in IDDM/NIDDM: differences and similarities.

Effects of antihypertensive drugs on renal function in patients with diabetic nephropathy.

P304

815-825

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/00912700022009549

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10934665

http://www.w3.org/2001/XMLSchema#string

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.

about

P2860

P2860

The future of clinical trials in chronic renal disease: outcome of an NIH/FDA/Physician Specialist Conference. Evaluation of Clinical Trial Endpoints in Chronic Renal Disease Study Group.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698